Buprenorphine + Naloxone Injection

Buprenorphine + Naloxone Injection

Form: Injection

Strength: 0.3 mg/mL, 0.6 mg/mL, 1 mg/mL

Reference Brands: Buprenex(US)

Category: Analgesic

Buprenorphine + Naloxone injection is approved in the US and EU for opioid dependence treatment, primarily used in clinical settings. In the US, brands like Sublocade are regulated by the FDA, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the EU, approval by EMA involves extensive dossiers, clinical data, and pharmacovigilance commitments. Due to high abuse potential, strict prescribing regulations and monitoring are enforced in both regions. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine + naloxone injection, ensuring adherence to European and US standards for safe, effective opioid dependency treatment.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Dexketoprofen + Tramadol tablets

Strength: 25 mg dexketoprofen + 37.5 mg tramadol

Form: Tablets

Reference Brands: Enantyum(EU)

View Details Get Enquiry
Paracetamol + Codeine tablets

Strength: 300 mg paracetamol + 30 mg codeine; 300 mg + 60 mg

Form: Tablets

Reference Brands: Tylenol with Codeine(US)

View Details Get Enquiry
Aceclofenac + Paracetamol tablets

Strength: 100 mg Aceclofenac + 325 mg Paracetamol

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details Get Enquiry
Tramadol + Paracetamol tablets

Strength: 37.5 mg tramadol + 325 mg paracetamol; 75 mg + 650 mg

Form: Oral Tablets

Reference Brands: Ultracet(US); Tramacet(EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.